Susquehanna International Group, LLP Arrowhead Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $83,248 - $127,022	4,300 Added 1.64%	265,700 $5.14 Million
Q2 2024 Aug 15, 2024	BUY	$21.87 - $28.24 $402,408 - $519,616	18,400 Added 7.57%	261,400 $6.79 Million
Q1 2024 May 07, 2024	BUY	$27.21 - $39.48 $1.15 Million - $1.67 Million	42,400 Added 21.14%	243,000 $6.95 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $2.36 Million - $3.45 Million	111,100 Added 124.13%	200,600 $6.14 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $982,500 - $1.35 Million	-37,500 Reduced 29.53%	89,500 $2.4 Million
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $357,272 - $587,596	14,200 Added 12.59%	127,000 $4.53 Million
Q1 2023 May 16, 2023	SELL	$23.68 - $38.51 $1.44 Million - $2.35 Million	-60,900 Reduced 35.06%	112,800 $2.87 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $795,200 - $1.15 Million	28,400 Added 19.55%	173,700 $7.05 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $829,640 - $1.35 Million	-28,000 Reduced 16.16%	145,300 $4.8 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $669,739 - $1.22 Million	-24,100 Reduced 12.21%	173,300 $6.1 Million
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $629,958 - $1.11 Million	-15,900 Reduced 7.45%	197,400 $9.08 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $1.45 Million - $2.05 Million	-24,900 Reduced 10.45%	213,300 $14.1 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $3.78 Million - $5.5 Million	64,700 Added 37.29%	238,200 $14.9 Million
Q2 2021 Aug 11, 2021	SELL	$62.15 - $90.32 $609,070 - $885,135	-9,800 Reduced 5.35%	173,500 $14.4 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $4.79 Million - $7.07 Million	-78,100 Reduced 29.88%	183,300 $12.2 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $749,322 - $1.46 Million	-17,100 Reduced 6.14%	261,400 $20.1 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $1.96 Million - $3.02 Million	-59,000 Reduced 17.48%	278,500 $12 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $57,464 - $95,194	-2,200 Reduced 0.65%	337,500 $14.6 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $18,504 - $56,808	-900 Reduced 0.26%	339,700 $9.77 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $2.53 Million - $6.56 Million	89,900 Added 35.86%	340,600 $21.6 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $2.64 Million - $3.5 Million	-100,400 Reduced 28.6%	250,700 $7.07 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $261,450 - $432,300	15,000 Added 4.46%	351,100 $9.3 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $1.76 Million - $2.94 Million	145,700 Added 76.52%	336,100 $6.17 Million
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $489,744 - $898,320	-45,600 Reduced 19.32%	190,400 $2.37 Million
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $1.01 Million - $1.46 Million	-71,800 Reduced 23.33%	236,000 $4.52 Million
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $942,123 - $2.07 Million	147,900 Added 92.5%	307,800 $4.19 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $323,640 - $664,680	87,000 Added 119.34%	159,900 $1.15 Million
Q4 2017 Feb 14, 2018	BUY	$3.14 - $4.5 $107,388 - $153,900	34,200 Added 88.37%	72,900 $268,000
Q3 2017 Nov 14, 2017	BUY	$1.69 - $4.33 $65,403 - $167,571	38,700	38,700 $168,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.97B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account